Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hippocampus | 10 | 2017 | 266 | 1.450 |
Why?
|
| Epilepsy, Temporal Lobe | 5 | 2023 | 30 | 1.040 |
Why?
|
| Electroencephalography | 4 | 2024 | 80 | 1.010 |
Why?
|
| Magnetic Resonance Imaging | 13 | 2023 | 1059 | 0.830 |
Why?
|
| Memory Disorders | 2 | 2017 | 154 | 0.590 |
Why?
|
| Neural Pathways | 1 | 2017 | 61 | 0.540 |
Why?
|
| Alzheimer Disease | 6 | 2019 | 2036 | 0.480 |
Why?
|
| Temporal Lobe | 3 | 2023 | 87 | 0.450 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2011 | 25 | 0.440 |
Why?
|
| Epilepsy | 3 | 2018 | 68 | 0.390 |
Why?
|
| White Matter | 1 | 2014 | 131 | 0.390 |
Why?
|
| Parahippocampal Gyrus | 1 | 2011 | 5 | 0.360 |
Why?
|
| Amnesia | 2 | 2011 | 21 | 0.340 |
Why?
|
| Drug Resistant Epilepsy | 2 | 2023 | 11 | 0.330 |
Why?
|
| Brain Mapping | 5 | 2016 | 145 | 0.320 |
Why?
|
| Atrophy | 5 | 2014 | 83 | 0.290 |
Why?
|
| Organ Size | 6 | 2014 | 94 | 0.270 |
Why?
|
| Entorhinal Cortex | 4 | 2012 | 32 | 0.260 |
Why?
|
| Nerve Fibers | 1 | 2006 | 12 | 0.260 |
Why?
|
| Aging | 4 | 2018 | 1483 | 0.250 |
Why?
|
| Humans | 21 | 2024 | 25967 | 0.240 |
Why?
|
| Cerebral Cortex | 2 | 2017 | 151 | 0.240 |
Why?
|
| Female | 18 | 2018 | 14734 | 0.240 |
Why?
|
| Memory | 4 | 2011 | 285 | 0.240 |
Why?
|
| Male | 15 | 2018 | 14277 | 0.220 |
Why?
|
| Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 3 | 2018 | 11 | 0.190 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 2 | 2012 | 4 | 0.190 |
Why?
|
| Potassium Channels | 2 | 2012 | 37 | 0.180 |
Why?
|
| Aged | 11 | 2018 | 8732 | 0.180 |
Why?
|
| Neuroimaging | 3 | 2018 | 120 | 0.170 |
Why?
|
| Membrane Proteins | 2 | 2012 | 169 | 0.170 |
Why?
|
| Neurology | 1 | 2019 | 37 | 0.150 |
Why?
|
| Channelopathies | 1 | 2018 | 6 | 0.150 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2018 | 9 | 0.150 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 45 | 0.140 |
Why?
|
| Pyramidal Cells | 1 | 2018 | 35 | 0.140 |
Why?
|
| Neuronal Plasticity | 1 | 2018 | 48 | 0.140 |
Why?
|
| Adult | 6 | 2017 | 7662 | 0.140 |
Why?
|
| Magnetoencephalography | 1 | 2017 | 2 | 0.130 |
Why?
|
| Brain Waves | 1 | 2016 | 5 | 0.130 |
Why?
|
| Brain | 3 | 2011 | 1569 | 0.130 |
Why?
|
| Electric Stimulation | 1 | 2016 | 50 | 0.130 |
Why?
|
| Young Adult | 5 | 2016 | 1941 | 0.130 |
Why?
|
| Functional Laterality | 4 | 2014 | 61 | 0.120 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2016 | 51 | 0.120 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2016 | 76 | 0.120 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 1757 | 0.110 |
Why?
|
| Neurosurgical Procedures | 1 | 2016 | 143 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 159 | 0.110 |
Why?
|
| Aged, 80 and over | 4 | 2012 | 4641 | 0.100 |
Why?
|
| Risk | 1 | 2014 | 202 | 0.100 |
Why?
|
| Perforant Pathway | 1 | 2012 | 3 | 0.100 |
Why?
|
| Axons | 1 | 2012 | 28 | 0.090 |
Why?
|
| Middle Aged | 9 | 2018 | 8772 | 0.090 |
Why?
|
| Protein Subunits | 1 | 2011 | 18 | 0.090 |
Why?
|
| Gene Deletion | 1 | 2011 | 41 | 0.090 |
Why?
|
| Positron-Emission Tomography | 2 | 2010 | 84 | 0.090 |
Why?
|
| Biomarkers | 1 | 2014 | 544 | 0.090 |
Why?
|
| Headache | 1 | 2011 | 37 | 0.090 |
Why?
|
| Cohort Studies | 2 | 2018 | 1806 | 0.090 |
Why?
|
| Implantable Neurostimulators | 1 | 2010 | 8 | 0.090 |
Why?
|
| Seizures | 2 | 2023 | 68 | 0.080 |
Why?
|
| Frontal Lobe | 2 | 2011 | 78 | 0.080 |
Why?
|
| Neoplasms | 1 | 2010 | 230 | 0.070 |
Why?
|
| Depression | 1 | 2011 | 412 | 0.070 |
Why?
|
| Analgesia, Epidural | 1 | 2007 | 54 | 0.070 |
Why?
|
| Verbal Learning | 2 | 2005 | 29 | 0.070 |
Why?
|
| Longitudinal Studies | 1 | 2011 | 1333 | 0.070 |
Why?
|
| Pain | 1 | 2010 | 395 | 0.070 |
Why?
|
| Dementia | 1 | 2012 | 524 | 0.070 |
Why?
|
| Cognition | 1 | 2014 | 1250 | 0.060 |
Why?
|
| Parkinson Disease | 1 | 2012 | 640 | 0.060 |
Why?
|
| Pain Measurement | 1 | 2007 | 476 | 0.060 |
Why?
|
| Adolescent | 3 | 2016 | 2099 | 0.060 |
Why?
|
| Cognition Disorders | 1 | 2011 | 957 | 0.060 |
Why?
|
| Pain, Postoperative | 1 | 2007 | 309 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2018 | 3358 | 0.050 |
Why?
|
| Proof of Concept Study | 1 | 2023 | 10 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2018 | 3399 | 0.050 |
Why?
|
| Animals | 3 | 2018 | 3503 | 0.050 |
Why?
|
| Child | 2 | 2016 | 1217 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2016 | 466 | 0.050 |
Why?
|
| Peroxins | 2 | 2012 | 2 | 0.050 |
Why?
|
| Protein Transport | 2 | 2012 | 31 | 0.050 |
Why?
|
| Algorithms | 1 | 2023 | 345 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2012 | 408 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2019 | 20 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2019 | 31 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2018 | 26 | 0.040 |
Why?
|
| Action Potentials | 1 | 2018 | 82 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 214 | 0.030 |
Why?
|
| Mice | 2 | 2012 | 1352 | 0.030 |
Why?
|
| Malformations of Cortical Development, Group I | 1 | 2017 | 2 | 0.030 |
Why?
|
| Sensory Thresholds | 1 | 2016 | 23 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2017 | 64 | 0.030 |
Why?
|
| Age Factors | 1 | 2018 | 757 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 577 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2016 | 120 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2016 | 597 | 0.030 |
Why?
|
| Reference Values | 2 | 2005 | 181 | 0.030 |
Why?
|
| Internet | 1 | 2014 | 85 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 193 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 649 | 0.020 |
Why?
|
| Tissue Embedding | 1 | 2012 | 4 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 21 | 0.020 |
Why?
|
| Dentate Gyrus | 1 | 2012 | 6 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2012 | 18 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2012 | 44 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2012 | 54 | 0.020 |
Why?
|
| Transfection | 1 | 2012 | 121 | 0.020 |
Why?
|
| Valproic Acid | 1 | 2011 | 14 | 0.020 |
Why?
|
| Sclerosis | 1 | 2011 | 67 | 0.020 |
Why?
|
| Age of Onset | 1 | 2011 | 89 | 0.020 |
Why?
|
| Anticonvulsants | 1 | 2011 | 54 | 0.020 |
Why?
|
| Radioisotopes | 1 | 2010 | 13 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2012 | 512 | 0.020 |
Why?
|
| Genetic Therapy | 1 | 2011 | 84 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2010 | 36 | 0.020 |
Why?
|
| Rats | 1 | 2012 | 640 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2011 | 297 | 0.020 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2010 | 57 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2011 | 294 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2010 | 210 | 0.020 |
Why?
|
| Educational Status | 1 | 2011 | 282 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 655 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2010 | 404 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2012 | 1150 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 851 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 868 | 0.020 |
Why?
|
| Incidence | 1 | 2007 | 729 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2003 | 103 | 0.010 |
Why?
|